IDH wild type
Showing 1 - 25 of >10,000
Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)
Recruiting
- Glioblastoma, IDH-wildtype
- MGMT-Methylated Glioblastoma
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Oct 18, 2023
Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma, IDH-Wildtype
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
May 13, 2023
Glioblastoma Trial in Köln, München, Münster (5-aminolevulinic acid)
Recruiting
- Glioblastoma
- 5-aminolevulinic acid
-
Köln, Germany
- +2 more
Feb 2, 2022
Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)
Not yet recruiting
- Glioblastoma
- Dose escalation of radiation dose beyond the therapeutic standard
- (no location specified)
May 13, 2023
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Initial Radiological Diagnosis Eligible for Tumor Resection, Initial Radiological Diagnosis Compatible With Newly Diagnosed
Recruiting
- Initial Radiological Diagnosis Eligible for Tumor Resection
- +2 more
- SonoCloud-9 (SC9) device
- Temozolomide according Stupp protocol
-
Leuven, Belgium
- +6 more
Mar 28, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab and irinotecan
- (no location specified)
Jul 26, 2023
Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)
Recruiting
- Polyneuropathy
- Amyloidosis
- ECG + echocardiography
- Answering questionnaires
-
Jette, Belgium Capital City, BelgiumUZ Brussel
Jul 14, 2023
Colo-rectal Cancer Trial (biological, drug, procedure)
Not yet recruiting
- Colo-rectal Cancer
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- +8 more
- (no location specified)
Aug 28, 2023
Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib
Not yet recruiting
- Ovarian Cancer
- +4 more
- Fluzoparib Capsules
- Bevacizumab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cetntre
Sep 25, 2023
Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- mFOLFOX6 + Cetuximab
- mFOLFOX 6
-
Shanghai, ChinaZhongshan hosptial, Fudan University
Jul 14, 2023
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and
Recruiting
- Unresectable Colon Cancer Peritoneal Metastases
- PMMR/Ras/BRAF Wild-type
- Serplulimab Combined With FOLFIRI and Bevacizumab
-
Huzhou, Zhejiang, ChinaChangxing County People's Hospital
Feb 14, 2023
Vectibix With Chemotherapy for Metastatic Colorectal Cancer
Completed
- Wild-type RAS Metastatic Colorectal Cancer
- Panitumumab + Chemotherapy
- (no location specified)
Nov 4, 2022
Cholesterol Levels Trial in Alexandroupolis (Lacticaseibacillus with oats, Plain oats)
Active, not recruiting
- Cholesterol Levels
- Lacticaseibacillus with oats
- Plain oats
-
Alexandroupolis, East Macedonia And Thrace, GreeceDemocritus University of Thrace
Oct 25, 2023
Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)
Not yet recruiting
- Colorectal Cancer
- Ametumumab
- +3 more
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023
New Prognostic Score for Adult RAS Wild-type mCRC Treated With
Active, not recruiting
- Metastatic Colorectal Cancer
- RAS Wild-type
-
Freiburg, Baden-Württemberg, GermanyPraxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022
Ovarian Cancer Trial (Huaier granule)
Not yet recruiting
- Ovarian Cancer
- Huaier granule
- (no location specified)
Feb 28, 2023
Wild-type Amyloid Cardiopathy Trial in Bordeaux, Nantes, Toulouse (electromyogram)
Recruiting
- Wild-type Amyloid Cardiopathy
- electromyogram
-
Bordeaux, France
- +2 more
Jul 4, 2022